Presentations
Upcoming Events
Past Events
Vaccines Summit
November 13-15, 2024
Boston, MA
Q3 2024 GeoVax Labs, Inc. Business Update
November 12, 2024 - 4:30 PM ET
3rd Annual ROTH Healthcare Opportunities Conference
Emerging Growth Conference
| September 25, 2024 at 2:55 pm ET |
| Webcast |
H.C. Wainwright 26th Annual Global Investment Conference
| September 9, 2024 - 7:00 am ET |
| New York, NY |
| H.C. Wainwright Webcast |
Tribe Public’s Webinar Presentation and Q&A Event
Emerging Growth Conference
August 21, 2024 - 4:10 pm ET
Q2 2024 GeoVax Labs, Inc. Business Update
August 6, 2024 - 4:30 PM ET
Emerging Growth Conference
International Pandemic Sciences Conference 2024
July 1-2, 2024
Oxford, United Kingdom
BIO International Convention
ASCO Annual Meeting
May 31-June 4, 2024
Chicago, IL
Q1 2024 GeoVax Labs, Inc. Business Update
May 14, 2024 - 4:30 PM ET
World Vaccine Congress Washington 2024
April 1-4, 2024
Speaker: Mark Newman, PhD, Chief Scientific Officer
Session Title: Vaccine Induction of Broadly-Specific Antibody and T Cell Responses to Combat SARS-CoV-2 Variation
BIO-Europe - Spring
March 18-20, 2024
Barcelona, Spain
36th Annual Roth Conference
Q4/FY 2023 GeoVax Labs, Inc. Business Update
February 29, 2024 - 4:30 PM ET
BIO CEO & Investor Conference
Biotech Showcase
Emerging Growth Conference
NobleCon19
World Vaccine Congress, West Coast
November 27-30, 2023
Speaker: Don Diamond, Professor, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center
Session Title: COVID-19 Vaccines for immunocompromised patients
Speaker: Jason Comer, PhD, Associate Professor, Department of Microbiology and Immunology, University of Texas Medical Branch
Session Title: Design and evaluation of vaccines against hemorrhagic fevers using the MVA-VLP platform